| Literature DB >> 28923849 |
Sayyed K Zaidi1,2, Seth E Frietze3,2, Jonathan A Gordon1,2, Jessica L Heath1,4,2, Terri Messier1,2, Deli Hong1,5, Joseph R Boyd1, Mingu Kang1, Anthony N Imbalzano6, Jane B Lian1,2, Janet L Stein1,2, Gary S Stein7,2.
Abstract
Multiple mechanisms of epigenetic control that include DNA methylation, histone modification, noncoding RNAs, and mitotic gene bookmarking play pivotal roles in stringent gene regulation during lineage commitment and maintenance. Experimental evidence indicates that bivalent chromatin domains, i.e., genome regions that are marked by both H3K4me3 (activating) and H3K27me3 (repressive) histone modifications, are a key property of pluripotent stem cells. Bivalency of developmental genes during the G1 phase of the pluripotent stem cell cycle contributes to cell fate decisions. Recently, some cancer types have been shown to exhibit partial recapitulation of bivalent chromatin modifications that are lost along with pluripotency, suggesting a mechanism by which cancer cells reacquire properties that are characteristic of undifferentiated, multipotent cells. This bivalent epigenetic control of oncofetal gene expression in cancer cells may offer novel insights into the onset and progression of cancer and may provide specific and selective options for diagnosis as well as for therapeutic intervention.Entities:
Keywords: bivalency; cancer; epigenetic control; nuclear structure; oncofetal gene expression
Mesh：
Substances：
Year: 2017 PMID： 28923849 PMCID： PMC5686582 DOI： 10.1128/MCB.00352-17
Source DB: PubMed Journal: Mol Cell Biol ISSN： 0270-7306 Impact factor: 4.272